Explore/

Aging Baby Boomers

Aging Baby Boomers

1.57k followers10 symbols Watchlist by Yahoo Finance

This basket consists of stocks that benefit from the needs of aging baby boomers.

10 Symbols

To view complete list, get the Yahoo Finance App

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • Better Buy: Procter & Gamble vs. Philip Morris
    Motley Fool8 hours ago

    Better Buy: Procter & Gamble vs. Philip Morris

    Here's what actually makes the seemingly "weaker" company a better bet.

  • UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
    Zacks9 hours ago

    UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know

    UnitedHealth Group (UNH) closed at $249.64 in the latest trading session, marking a -1.05% move from the prior day.

  • MarketWatch12 hours ago

    FDA approves Allergan's CoolTone device for toning up abdomen, buttocks and thighs

    The U.S. Food and Drug Administration has approved Allergan Plc's CoolTone device for use in strengthening, toning and firming the abdominal area, buttocks and thighs, Allergan said Monday. CoolTone uses magnetic muscle stimulation to penetrate muscle layers, which then causes involuntary muscle contractions. The body responds to the contractions by strengthening muscle fibers, leading to increased muscle tone. The drugmaker said CoolTone has 50% more magnetic intensity than the leading competitor, but that claim has not been clinically established. Allergan also makes the CoolSculpting device, a non-surgical fat-elimination device that works by freezing and killing fat cells in targeted areas like the abdomen, flanks or under the chin. Shares of the drugmaker have fallen 3.4% so far this year, but were down as much as 12.5% in June before buzz of a possible company split helped bolster the stock price. Allergan has been dealing with some significant issues in the past year -- investors are worried about the future of Botox, the company's biggest earner, as it faces competition in the anti-wrinkle and injectable migraine treatment markets. Investors were also rattled by the failure of depression drug rapastinel -- once considered by many to be Allergan's next big blockbuster drug -- in clinical trials earlier this year. In May, Chief Executive Brent Saunders said he had heard investors' concerns "loud and clear," adding that "everything is on the table," including the possibility of splitting the company up.

  • Royal Caribbean enters joint venture to form new Miami-based company
    American City Business Journals13 hours ago

    Royal Caribbean enters joint venture to form new Miami-based company

    Royal Caribbean Cruises Ltd. has formed a new company through a joint venture that will develop, own and operate destinations in coastal cities. The new company, called Holistica Destinations Ltd., is a 50-50 partnership between the Miami-based cruise company (NYSE: RCL) and Mexico-based ITM Group. The two companies are searching for a CEO for Holistica, which will be headquartered in Miami.

  • Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids
    Zacks16 hours ago

    Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids

    Allergan's (AGN) Botox gets FDA approval for the 10th therapeutic indication, upper limb spasticity in pediatric patients, in the age group of 2 to 17 years.

  • Reuters17 hours ago

    CORRECTED-Trump to order hospitals to be transparent about healthcare costs

    President Donald Trump will sign an executive order aimed at requiring hospitals to be more transparent about prices before charging patients for healthcare services, Secretary of Health and Human Services Alex Azar said on Monday. The executive order will direct HHS to issue a rule that will mandate hospitals to disclose in an "easy-to-read, patient-friendly format" what prices patients and insurers will actually end up paying, Azar said. The order will ultimately require healthcare providers and insurers to provide patients with information about the out-of-pocket costs they'll face before they receive healthcare services, he said.

  • 3 Top Insurance Stocks to Buy Now
    Motley Fool19 hours ago

    3 Top Insurance Stocks to Buy Now

    These insurers could produce excellent returns in the coming years.

  • Church & Dwight Continues to Outperform with Its Earnings Growth
    Market Realist19 hours ago

    Church & Dwight Continues to Outperform with Its Earnings Growth

    Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five out of the past six quarters.

  • Barrons.com19 hours ago

    Estée Lauder CEO Fabrizio Freda on Makeup Trends and Chinese Millennials

    Under Estée Lauder chief Fabrizio Freda, one of our 2019 World’s Best CEOs, the company has conquered new markets and pumped up growth. Why Chinese millennials outspend their American counterparts.

  • TheStreet.com2 days ago

    Dow Ends Lower; Stocks Cap Record Week With Down Day

    The Dow Jones Industrial Average ended down Friday, but held onto most of the week's gains following reports that President Donald Trump ordered, but then rescinded, an airstrike on military installations in Iran. Canopy Growth is Real Money's Stock of the Day. advanced following a report in The Wall Street Journal that the company was ready to buy healthcare payments group Equian LLC for around $3.2 billion.

  • Does This Valuation Of Service Corporation International (NYSE:SCI) Imply Investors Are Overpaying?
    Simply Wall St.2 days ago

    Does This Valuation Of Service Corporation International (NYSE:SCI) Imply Investors Are Overpaying?

    Does the June share price for Service Corporation International (NYSE:SCI) reflect what it's really worth? Today, we...

  • Alibaba and JD.com Want to Lock in Merchants With Big Data Deals
    Motley Fool3 days ago

    Alibaba and JD.com Want to Lock in Merchants With Big Data Deals

    China’s two biggest e-commerce players are tethering more brands to their platforms with data services.

  • Is CareTrust REIT a Buy?
    Motley Fool3 days ago

    Is CareTrust REIT a Buy?

    By most metrics, CareTrust looks expensive. But there's a very good reason why investors should consider buying anyway.

  • Dow Jones Today: A Typical Summer Friday
    InvestorPlace4 days ago

    Dow Jones Today: A Typical Summer Friday

    Interestingly, June 21 marks the official start of summer, and the summer months often bring lethargy in the equity markets, particularly on Fridays. That was the case today as stocks, broadly speaking, were mostly listless.Source: Shutterstock To close the week, the S&P 500 fell a scant 0.13%, and the Nasdaq Composite lost 0.24%. The Dow Jones Industrial Average also lost 0.13%. Long-term investors can find some solace on the day of the summer solstice with an article in Barron's today indicating Dow 30,000 could arrive sooner than expected."To stick with our 2025 forecast now would be to suggest that stocks over the next 5½ years will climb just 2.1% a year, plus dividends," according to Barron's. "It's possible, but pessimistic. The Dow could reach 30,000 much sooner than 2025."InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe article indicates it is possible the Dow sees 30,000 sometime in 2021, a bullish forecast considering the blue-chip index closed around 26,800 today.That is a long-term forecast. Over the near-term, the Federal Reserve will likely dominate the conversation and that is not surprising. For investors hoping for rate cut this year, good news: Fed funds traders bet on such a move in record fashion this week, according to CNBC. Some Mild WinnersBy the end of the day, just two of the 30 Dow Jones stocks were sporting gains of 1% or more. The clear powerhouse was UnitedHealth Group (NYSE:UNH), which gained 1.82% on new that it is acquiring health-care payments provider Equian LLC for $3.2 billion. * The 7 Best Dow Jones Stocks to Buy for the Rest of 2019 That is a drop in the bucket for UnitedHealth, which has a market capitalization of $240 billion and a stellar return for Equian's private equity owner New Mountain, which purchased the company four years ago for just $225 million.Defensive names have been getting some attention here in recent weeks and with good reason. Today, Dow component Walmart (NYSE:WMT), on essentially no news to merit a move like this, jump 0.73% to hit an all-time high. The largest U.S. retailer is up almost 20% year-to-date.Pharmaceuticals giant Pfizer (NYSE:PFE) added 0.88% after the European Commission approved the company's TALZENNA treatment for breast cancer patients. The U.S. Food and Drug Administration (FDA) approved the treatment last October."We are thrilled that we can now offer these patients in Europe, who are often diagnosed at a younger age and have limited treatment options, an effective, once-daily, alternative treatment to chemotherapy," said Pfizer in a statement.Staying in the blue-chip pharmaceuticals space, Merck & Co. (NYSE:MRK) closed modestly lower, but three analysts raised price targets on the stock to $90, $95 and $96, respectively. In either case, that is some decent upside from Merck's Friday close around $84.50. Bottom Line on the Dow Jones TodayWith all the talk about a potential rate cut, investors should not forget that second-quarter earnings season will soon be here. While glum earnings may be baked into the market at current levels, investors should still expect some less-than-positive sentiment around the second-quarter numbers."As of today, the estimated earnings decline for the second quarter for the S&P 500 stands at -2.6%," said FactSet in a note out Friday. "If -2.6% is the actual earnings decline for the quarter, it will mark the first time the index has reported two straight quarters of year-over-year declines in earnings since Q1 2016 and Q2 2016. It will also mark the largest year-over-year decline in earnings since Q2 2016 (-3.2%)."Unfortunately, the same note indicates analysts are ratcheting down third-quarter estimates with the energy and technology sectors looking like the worst offenders.As of this writing, Todd Shriber did not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 7 Best Dow Jones Stocks to Buy for the Rest of 2019 * 5 Boring Stocks to Buy This Summer * 7 S&P 500 Stocks to Buy With Little Debt and Lots of Profits Compare Brokers The post Dow Jones Today: A Typical Summer Friday appeared first on InvestorPlace.

  • Dow Jones Fades Late, But UnitedHealth, Exxon Mobil Outperform; Small Caps Nailed
    Investor's Business Daily4 days ago

    Dow Jones Fades Late, But UnitedHealth, Exxon Mobil Outperform; Small Caps Nailed

    The Dow Jones came to within 44 points of its all-time high Friday but backed off highs. UnitedHealth and Exxon Mobil were top gainers in the Dow.

  • Carnival Lowers Its Outlook Again
    Motley Fool4 days ago

    Carnival Lowers Its Outlook Again

    The latest earnings report suggests that the cruise giant is falling behind industry peers.

  • Companies to Watch: Micron under pressure, Funko sees a pop, concerns for ExxonMobil
    Yahoo Finance4 days ago

    Companies to Watch: Micron under pressure, Funko sees a pop, concerns for ExxonMobil

    Micron, Funko, ExxonMobil, UnitedHealth and McDonald’s are the companies to watch.

  • Benzinga4 days ago

    CNBC: Retail Pharmacies More Worried About Amazon Than They Admit

    Are traditional retail pharmacies and insurance companies worried about Amazon.com, Inc. (NASDAQ: AMZN )'s push into their respective territories? Public comments from management teams brush off any concerns, ...

  • Stocks - Canopy Growth, Caterpillar Fall Premarket
    Investing.com4 days ago

    Stocks - Canopy Growth, Caterpillar Fall Premarket

    Investing.com - Stocks in focus in premarket trading on Friday:

  • Good Time to Sell Health Care Stocks
    Investopedia4 days ago

    Good Time to Sell Health Care Stocks

    Bipartisan tongue-lashing and legislative proposals should put a lid on health care stocks during the 2020 election cycle.

  • TheStreet.com4 days ago

    UnitedHealth Dip on Report It May Buy Payments Group Equian for $3.2 Billion

    shares edged lower Friday following report that it's ready to buy healthcare payments group Equian LLC for around $3.2 billion. The Wall Street Journal said the deal would see Equian sold by its private equity owners, Mountain Capital, and likely merged into UnitedHealth's Optum division, which recently closed its $4.3 billion purchase of DaVita medical group after getting Federal Trade Commission approval on Wednesday. UnitedHealth must now sell one of DaVita's units in Las Vegas to a Utah-based group called Intermountain Healthcare in order to abide by the FTC's decision.

  • Carnival (CCL) Q2 Earnings Top, Weak View Hurts Cruise Stocks
    Zacks4 days ago

    Carnival (CCL) Q2 Earnings Top, Weak View Hurts Cruise Stocks

    Carnival's (CCL) top-line improvement in second-quarter fiscal 2019 can be attributed strength in passenger tickets, and onboard and other as well as tour and other businesses.

  • MarketWatch4 days ago

    Allergan's sBLA for Botox for pediatric patients approved by FDA

    Allergan PLC said Friday that its supplemental biologics application (sBLA) for Botox for the treatment of upper limb spasticity in pediatric patients, from ages 2 to 17, was approved by the U.S. Food and Drug Administration. Botox was granted a 6-month Priority Review by the FDA. Upper limb spasticity often results in muscle tightness and stiffness, and can interfere with movement at the joints. Common causes of spasticity in children include cerebral palsy, traumatic brain injury, multiple sclerosis, spinal cord injury and stroke. Allergan said the FDA is also reviewing an sBLA for the use of Botox to treatment pediatric patients with lower limb spasticity, and expects a decision by the end of the year. Allergan's stock, which is still inactive in premarket trade, has fallen 15% over the past three months, while the SPDR Health Care Select Sector ETF has gained 1.1% and the S&P 500 has tacked on 3.5%.

  • UnitedHealth to buy health-payments business Equian for $3.2B, report says
    American City Business Journals4 days ago

    UnitedHealth to buy health-payments business Equian for $3.2B, report says

    UnitedHealth Group Inc., which just closed on a multibillion-dollar acquisition this week, isn't waiting long for its next big deal: The Wall Street Journal reports that the insurance giant has agreed to buy Equian, which processes health care payments.